Explore more publications!

Press Releases

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia
ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim® Neuromodulation Technology
RNA Analysis Market Size Worth USD 23.39 Billion by 2035 Fueled by Expansion of RNA Therapeutics and Precision Medicine
Single-Use Disposable Medical Devices Market Size to Reach USD 310.92 Billion by 2035 Driven by Chronic Disease Burden and Home Healthcare Demand
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China
Semiconductor Market Size Forecasted to Reach USD 1.27 Trillion by 2035 Driven by AI, IoT, and Smart Manufacturing Expansion
Satellite IoT Market Size Worth USD 15.77 Billion by 2035 Amid Rapid Adoption in Asset Tracking and Smart Infrastructure
Advanced Coating for Healthcare Packaging Market Trends 2026-2035
Generic Drugs Market Size to Reach USD 762.48 Billion by 2035 Driven by Rising Chronic Disease Burden and Cost-Control Focus
Top Operating Lamp Manufacturers Driving Innovation in Medical Equipment
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease
Skincare Market Size to Reach USD 340.25 Billion by 2035, Driven by Clean Beauty and Wellness Trends
BOBA CHiC to Debut Plant-Based Innovations and Award-Winning Functional Beverages at Expo West 2026
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
Pharmaceutical Packaging Laminates Market Trends for 2026
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
German-Japanese Medical Tech Innovation Celebrated by Birger Nispel International Academy at MEDICA
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions